Initiation of Noninvasive Ventilation in ALS Patients With Chronic Respiratory Insufficiency
NCT ID: NCT06286917
Last Updated: 2024-03-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
120 participants
INTERVENTIONAL
2024-03-05
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Nocturnal Non-invasive Ventilation in Patients With Amyotrophic Lateral Sclerosis
NCT00958048
Monitoring of Non-invasive Ventilation During Sleep in ALS
NCT01889043
Factors Associated With Success of NIPPV in ALS Patients
NCT05581771
Efficacy of Noninvasive Ventilation in Amyotrophic Lateral Sclerosis (ALS)
NCT00537641
Nightime NIV Initiation in Amyotrophic Lateral Sclerosis in an Outpatient Setting
NCT02759003
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NIV initiation in outpatient clinic in patients with ALS
Starting the NIV at the outpatient clinic
NIV initiation in patients with ALS
NIV initiation according to standard care
NIV initiation in pulmonary ward in patients with ALS
Starting the NIV in the pulmonary ward
NIV initiation in patients with ALS
NIV initiation according to standard care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
NIV initiation in patients with ALS
NIV initiation according to standard care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* chronic respiratory insufficiency or significant respiratory muscle weakness caused by ALS
Exclusion Criteria
* contraindication to NIV therapy
* another severe disease with a prognosis of less than one year
* ventilation via an artificial airway, tracheostomy
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tampere University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Heidi Rantala
Consultant
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tampere University Hospital
Tampere, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R24001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.